GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Pharmigene Inc (ROCO:7595) » Definitions » Accounts Payable & Accrued Expense

Pharmigene (ROCO:7595) Accounts Payable & Accrued Expense : NT$22.3 Mil (As of Jun. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Pharmigene Accounts Payable & Accrued Expense?

Pharmigene's quarterly accounts payable & accrued expense increased from Jun. 2023 (NT$17.7 Mil) to Dec. 2023 (NT$26.4 Mil) but then declined from Dec. 2023 (NT$26.4 Mil) to Jun. 2024 (NT$22.3 Mil).

Pharmigene's annual accounts payable & accrued expense increased from Dec. 2021 (NT$14.9 Mil) to Dec. 2022 (NT$23.6 Mil) and increased from Dec. 2022 (NT$23.6 Mil) to Dec. 2023 (NT$26.4 Mil).


Pharmigene Accounts Payable & Accrued Expense Historical Data

The historical data trend for Pharmigene's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmigene Accounts Payable & Accrued Expense Chart

Pharmigene Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial 13.53 12.92 14.93 23.58 26.38

Pharmigene Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.26 23.58 17.69 26.38 22.33

Pharmigene Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.


Pharmigene Business Description

Traded in Other Exchanges
N/A
Address
No. 17, Lane 171, Section 2, Jiuzong Road, 4th Floor, Neihu District, Taipei, TWN, 11494
Pharmigene Inc is engaged in the development and sales of pharmaceutical genetic diagnostic products. Also, the company provides medical and drug testing services and equipment.

Pharmigene Headlines

No Headlines